glp-1 news 2025 november Beyond GLP-1: the next wave of weight-loss medication innovation Sen. Lesser Highlights CT's Generic

(2020) 30:R7905

Cognition improved in exenatide treated patients in fluid intelligence (baseline 38.4 (8.2), 12 weeks 52.9 (6.6), p = 0.0005), processing speed (baseline 43.7 (9.4), 12 weeks 58.4 (10.4), p = 0.0058) and episodic memory (baseline 49.4 (5.3), 12 weeks 62.1 (13.2), p = 0.0315)

This is related to rapid weight loss and calorie restriction, not the medication itself

What Are Healing Peptides and How Do They Work

Collagen supplementation may provide additional structural support for connective tissue injuries

This difference reflects their individual stability testing, formulation specifics, and quality assurance practices